A Study of PD-1 Inhibitors Combined With Fruquintinib and Chemotherapy in First-line Treatment of HER2-negative Advanced G/GEJ Cancer

Conditions: Gastric Cancer/Adenocarcinoma of Esophagogastric Junction Interventions: Drug: Fruquintinib 、Nivolumab、Sintilimab、Oxaliplatin、Teysuno、Capecitabine Sponsors: Fudan University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials